Immunofluorescence staining of helper CD4+ and cytotoxic CD8+ T cells in tumor tissues collected 3 and 7 days after treatment revealed a significant increase in CD8+ T cells in tumors treated with the SHV pulse protocol on day 7 compared with those in all groups on day 3. This evidence concerns the gene CD8A and neoplasm.